Expired CME Article

The Management of Post Traumatic Stress Disorder (PTSD) in the Primary Care Setting

Authors: William V. Bobo, MD, Christopher H. Warner, MD, MAJ, MC, USA, Carolynn M. Warner, MD, MAJ, MC, USA

Abstract

Recent geopolitical events, including the terrorist attacks on the United States on September 11, 2001, and ongoing military operations in Iraq, have raised awareness of the often severe psychological after-effects of these and other types of traumatic events. Post traumatic stress disorder (PTSD) represents the most severe of these sequelae. PTSD is an under-recognized and under-treated chronic anxiety disorder associated with significant psychosocial morbidity, substance abuse, and a number of other negative health outcomes. Fortunately, the biologic underpinnings of this complex disorder and new advances in treatment are being realized. Early detection by primary care providers and rapid initiation of treatment are the keys to successful management of the disorder.


Key Points


* Post traumatic stress disorder is an anxiety disorder marked by re-experiencing a traumatic event, associated hyperarousal symptoms, and avoidance of anxiety triggers.


* Post traumatic stress disorder is treated with a multidisciplinary approach including both pharmacological and psychological interventions.


* Early detection by primary care providers and rapid initiation of treatment are the keys to successful management of the disorder.


* Selective serotonin re-uptake inhibitors are the first line of pharmacologic management.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Rodriguez BF, Weisberg RB, Pagano ME, et al. Mental health treatment received by primary care patients with posttraumatic stress disorder. J Clin Psychiatry 2003;64:1230–1236.
 
2. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders, 4th ed. Washington, DC, American Psychiatric Association, 2000.
 
3. Kessler RC, Sonnega A, Bromet E, et al. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995;52:1048–1060.
 
4. Shalev AY. Acute stress reactions in adults. Biol Psychiatry 2002;51:532–543.
 
5. True WR, Rice J, Eisen SA, et al. A twin study of genetic and environmental contributions to liability for posttraumatic stress symptoms. Arch Gen Psychiatry 1993;50:257–264.
 
6. Ursano RJ, Bell C, Eth S, et al. Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. Am J Psychiatry 2004;161 (Suppl 11):3–31.
 
7. Davidson JR, Hughes D, Blazer DG, et al. Post-traumatic stress disorder in the community: an epidemiological study. Psychol Med 1991;21:713–721.
 
8. Engel CC, Liu X, Miller RF, et al. Relationship of physical symptoms to posttraumatic stress disorder among veterans seeking care for gulf war-related health concerns. Psychosom Med 2000;62:739–745.
 
9. Sperry L. Psychopharmacology and Psychotherapy: Strategies for Maximizing Treatment Outcomes (Mental Health Practice Under Managed Care, No 1) New York, Brunner Mazel, Inc., 1995.
 
10. Foa EB. Psychosocial treatment of posttraumatic stress disorder. J Clin Psychiatry 2000;61 (Suppl 5):43–48.
 
11. Bisson J, Andrew M. Psychological treatment of post-traumatic stress disorder (PTSD). Cochrane Database Syst Rev 2005;2:CD003388.
 
12. Physicians' Desk Reference, 59th ed. Montvale, NJ, Thomson PDR, 2005, pp 731, 1269, 1282, 1585, 1592, 1655, 1659, 1663, 1873, 1925-6, 2213, 2458, 2578, 2681, 3220, 3296, 3321, 3326, 3430.
 
13. Cooper J, Carty J, Creamer M. Pharmacotherapy for posttraumatic stress disorder: empirical review and clinical recommendations. Aust N Z J Psyciatry 2005;39:674–682.
 
14. Bisson J. Post-traumatic stress disorder. Clin Evid 2003;9:1091– 1102.
 
15. Stein DJ, Bandelow B, Hollander E, et al. WCA recommendations forthe long-term treatment of generalized anxiety disorder. CNS Spectr 2003;8 (8 Suppl 1):53–61.
 
16. Kimble M, Kaufman M. Clinical correlates of neurological change in posttraumatic stress disorder: an overview of critical systems. Psychiatr Clin North Am 2004;27:49–65.
 
17. Schoenfeld FB, Marmar CR, Neylan TC. Current concepts in pharmacotherapy for posttraumatic stress disorder. Psychiatr Serv 2004;55:519–531.
 
18. Hamner MB, Robert S, Frueh BC. Treatment-resistant posttraumatic stress disorder: strategies for intervention. CNS Spectr 2004;9:740–752.
 
19. Ahearn EP, Krohn A, Connor KM, et al. Pharmacologic treatment of posttraumatic stress disorder: a focus on antipsychotic use. Ann Clin Psychiatry 2003;15:193–201.